Cannabis & Hemp Stocks Investment Tools – Schedule Demo Now!

Columbia Care Opens in 16th U.S. Jurisdiction with Receipt of Approval to Operate in Virginia

One of five licensed operators designated as an essential service, Columbia Care will provide access to patients state-wide through its fully integrated facilities in Hampton Bays and direct-to-patient via home delivery

Columbia Care Opens in 16th U.S. Jurisdiction with Receipt of Approval to Operate in VirginiaNEW YORK–(BUSINESS WIRE)–Columbia Care, Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”) announced that it has received approval from the Virginia Board of Pharmacy to commence vertically integrated operations for the cultivation, manufacture and sale of medical cannabis. The Company also announced the completion of its 65,000 square foot vertically-integrated Portsmouth facility.

Although Columbia Care will launch dispensary operations with state-wide home delivery to expedite patient access, the Company anticipates adding up to five additional dispensaries in the eastern, coastal Hampton Bays/Norfolk greater metro area in 2020 (subject to final approval by Governor Northam of the unanimously passed Senate Bill (SB976) authorizing the expansion).

“We are proud and grateful to be one of the first cannabis operators approved to go to market in Virginia and serve one of the most populous regions in the Commonwealth,” said Columbia Care CEO Nicholas Vita. “Located in the heart of the Tidewater Region, we are excited to contribute to Virginia’s economic success as we emerge from the uncertainty caused by COVID-19. In addition to our full line of pharmaceutical products, patient access will be enhanced by CC@Home, our proprietary home delivery service, as well as the CNC Card, the nation’s first credit card for purchasing cannabis. This is great news for Virginia, Columbia Care and most of all, the patients who have been looking forward to a safe and regulated marketplace to access their medicine.”

About Columbia Care Inc.
Columbia Care is one of the largest and most experienced cultivators, manufacturers and providers of medical and adult-use cannabis products and related services with licenses in 19 jurisdictions (1,2,3) in the US and the EU. Columbia Care has completed more than 1.6 million sales transactions since inception and working in collaboration with renowned and innovative teaching hospitals and medical centers globally, continues to be a patient-centered health and wellness company setting the standard for compassion, professionalism, quality, care and innovation in the rapidly expanding cannabis industry. For more information on Columbia Care, please visit

Caution Concerning Forward-Looking Statements
This press release contains certain statements that constitute forward-looking information within the meaning of applicable securities laws and reflect the Company’s current expectations regarding future events. The Company has made assumptions with respect to the final approval by the Governor of SB976 and investors should consider that this assumption, although considered reasonable by the Company at the time of preparation, may prove to be incorrect, as well as other risk factors discussed under “Risk Factors” in Columbia Care’s Annual Information Form dated March 31, 2020, filed with the applicable Canadian securities regulatory authorities on SEDAR at and described from time to time in documents filed by the Company with Canadian securities regulatory authorities._______________________________

(1) Includes Colorado, subject to completion of the acquisition of The Green Solution
(2) Missouri subject to the successful completion of a management services agreement through which the company intends to provide consultative services
(3) Includes West Virginia industrial hemp cultivation license


Investor Contact:
Gary F. Santo, Jr.
Investor Relations

Media Contact:
Gabriella Velez

Columbia Care to Operate in Virginia

About Cannin: Cannabis and Hemp Investment Experts

Market analysts expect the cannabis and hemp industry will have an annual value exceeding $75 Billion in the next decade. The time to invest in cannabis and hemp stocks is now. Are you looking to buy stock in hemp companies or cannabis companies? Interested in emerging penny pot stock companies? Looking for the best Canadian pot company to invest in? Cannin is your trusted resource for information about Cannabis and Hemp stock investment opportunities. Our global team of experts evaluates emerging cannabis and hemp companies. We aggregate hundreds of hours of research and provide tips on the best cannabis and hemp stock investments for 2020. We provide the latest marijuana and hemp investment news and analysis. Visit our site for breaking cannabis investing news and featured companies, sign up for the free Cannin Chronicle or get a free trial of our smart cannabis and hemp stock algorithm to take the guesswork out of profiting from this exciting industry. Predict the price of cannabis and hemp stocks hours in advance with our proven machine learning algorithm. Is it too late to invest in marijuana companies like Columbia Care? No! This is the perfect time to invest.

Profit from the best Cannabis and Hemp stocks – we’ll show you how at